Medical Management of Cardiovascular Disease

Kyle Steiger; Ana Fuentes; Young Erben

doi:10.1016/j.suc.2023.04.019

Medical Management of Cardiovascular Disease

Surg Clin North Am. 2023 Aug;103(4):565-575. doi: 10.1016/j.suc.2023.04.019. Epub 2023 May 16.

Authors

Kyle Steiger¹, Ana Fuentes², Young Erben³

Affiliations

¹ Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
² Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL, USA.
³ Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL, USA. Electronic address: erben.young@mayo.edu.

PMID: 37455025
DOI: 10.1016/j.suc.2023.04.019

Abstract

We offer an overview of lipid lowering, antiplatelet, antihypertensive, and glucose-lowering therapies for vascular surgeons and their respective medical teams. Further reviews should offer additional guidance on smoking cessation, exercise therapy, and nutritional optimization.

Keywords: Cardiovascular disease; Diabetes mellitus; Hyperlipidemia; Hypertension; Medical management; Non surgical management.

Publication types

Review

MeSH terms

Antihypertensive Agents / therapeutic use
Cardiovascular Diseases* / therapy
Humans
Hypertension* / drug therapy
Risk Factors
Smoking Cessation*

Substances

Antihypertensive Agents